Your heart beats approximately 100,000 times every day in a precise, coordinated rhythm that delivers oxygenated blood to every cell in your body. When that rhythm breaks down — when the upper chambers of the heart begin to quiver chaotically instead of contracting effectively — the condition is called atrial fibrillation, commonly shortened to AFib.
AFib is the most common sustained cardiac arrhythmia in the world, affecting an estimated 33.5 million people globally. In the United States alone, between 2.7 and 6.1 million adults have AFib, and that number is expected to double by 2030 as the population ages. The condition is not merely an inconvenience — untreated AFib increases the risk of stroke fivefold and significantly raises the risk of heart failure, dementia, and death.
Yet AFib is highly treatable. With proper diagnosis, medication management, lifestyle modifications, and in some cases procedural interventions, most people with AFib live full, active lives. The American Heart Association provides extensive resources for patients, and this guide distills the essential information you need to understand and manage this common condition.
What Happens During Atrial Fibrillation
In a healthy heart, electrical signals originate in the sinoatrial (SA) node — the heart's natural pacemaker — located in the right atrium. These signals travel through the atria (the two upper chambers) in an orderly fashion, causing them to contract and push blood into the ventricles (the two lower chambers). The signal then passes through the atrioventricular (AV) node and into the ventricles, triggering the powerful contraction that pumps blood to the lungs and the rest of the body.
During AFib, chaotic electrical signals fire from multiple locations throughout the atria, causing them to quiver or fibrillate at rates of 300 to 600 times per minute instead of contracting in a coordinated pattern at 60 to 100 beats per minute. The AV node acts as a gatekeeper, blocking most of these chaotic signals from reaching the ventricles, but enough get through to produce an irregular and often rapid ventricular rate.
The result is a heart rhythm that is both irregularly irregular (the time between beats varies unpredictably) and often too fast. The quivering atria cannot pump blood effectively, leading to blood pooling in the atrial chambers — a situation that significantly increases the risk of blood clot formation.
Types of Atrial Fibrillation
AFib is classified by its duration and pattern, which has important implications for treatment strategy.
Paroxysmal AFib comes and goes on its own, with episodes lasting from minutes to up to seven days before the heart returns to normal rhythm spontaneously. Episodes may be infrequent (a few times per year) or frequent (several times per week). Paroxysmal AFib can progress to more persistent forms over time.
Persistent AFib lasts longer than seven days and does not convert back to normal rhythm on its own. Medical intervention — either medications or electrical cardioversion (a controlled shock to reset the heart's rhythm) — is needed to restore normal rhythm.
Long-standing persistent AFib has been present continuously for more than twelve months. Rhythm control becomes progressively more difficult the longer AFib persists, as the atria undergo structural remodeling (fibrosis) that perpetuates the arrhythmia.
Permanent AFib is a clinical decision rather than a physiological classification — it refers to AFib where the patient and physician have decided to stop attempting rhythm restoration and focus instead on controlling the ventricular rate and managing stroke risk.
Recognizing the Symptoms
AFib symptoms vary enormously between individuals. Some people experience dramatic, unmistakable symptoms, while others have no symptoms at all and are diagnosed incidentally during routine medical exams or when they develop a complication like stroke.
Common symptoms include palpitations — a fluttering, racing, or pounding sensation in the chest that many patients describe as feeling like their heart is "flip-flopping" or "skipping beats." Fatigue and reduced exercise tolerance occur because the heart is pumping less efficiently. Shortness of breath, particularly during physical activity or when lying down, results from reduced cardiac output and possible fluid backup in the lungs. Dizziness or lightheadedness occurs when the heart rate is either too fast or too slow to maintain adequate blood pressure. Chest discomfort or pressure may accompany AFib episodes, though severe chest pain should always be evaluated emergently to rule out a heart attack.
Approximately one-third of AFib patients are asymptomatic, which is concerning because the stroke risk exists regardless of whether you feel the arrhythmia. This is one reason smartwatches and wearable devices capable of detecting irregular heart rhythms have become valuable screening tools — they can identify AFib in people who would otherwise remain undiagnosed until a complication occurs.
Risk Factors and Causes
Age is the strongest risk factor for AFib. The prevalence increases dramatically with each decade of life — approximately 1 percent of people in their fifties have AFib, compared to nearly 10 percent of those over eighty.
Hypertension (high blood pressure) is the most common modifiable risk factor, present in roughly 60 to 80 percent of AFib patients. Chronic high blood pressure causes structural changes in the left atrium (enlargement and fibrosis) that create the substrate for AFib to develop and persist.
Other significant risk factors include obesity (which increases AFib risk by 49 percent for every 5-unit increase in BMI), obstructive sleep apnea (present in approximately 50 percent of AFib patients), heart failure, valvular heart disease (particularly mitral valve disease), diabetes, chronic kidney disease, thyroid disorders (especially hyperthyroidism), excessive alcohol consumption (known as "holiday heart syndrome"), and endurance athletics (a paradoxical risk — extreme endurance training can cause atrial remodeling that promotes AFib).
The Stroke Connection
The most dangerous consequence of AFib is stroke. When the atria fibrillate instead of contracting, blood pools and stagnates in the atrial appendages — small pouches in the atrial walls. This stagnant blood can form clots that, if dislodged, travel to the brain and block an artery, causing an ischemic stroke.
AFib-related strokes tend to be more severe than strokes from other causes because the clots that form in the heart are typically larger, blocking bigger arteries and damaging more brain tissue. About 15 to 20 percent of all ischemic strokes are attributed to AFib.
Stroke risk assessment in AFib uses the CHA₂DS₂-VASc scoring system, which assigns points for Congestive heart failure, Hypertension, Age (65-74 gets 1 point, 75+ gets 2 points), Diabetes, prior Stroke or TIA (2 points), Vascular disease, and Sex category (female gets 1 point). Higher scores indicate higher annual stroke risk and stronger indication for blood-thinning medication.
Treatment Strategies
AFib management revolves around three goals: controlling the heart rate, restoring and maintaining normal rhythm when appropriate, and preventing stroke.
Rate Control
Rate control medications slow the ventricular response to the chaotic atrial signals, bringing the heart rate into a more normal range (typically below 110 beats per minute at rest). Beta-blockers (metoprolol, atenolol) and calcium channel blockers (diltiazem, verapamil) are first-line rate control agents. Digoxin may be added for additional rate control, particularly in patients with heart failure.
Rate control is often the initial strategy, particularly in older patients, those with minimal symptoms, and those with long-standing persistent or permanent AFib where rhythm restoration is unlikely to succeed long-term.
Rhythm Control
Rhythm control aims to restore and maintain normal sinus rhythm through medications (antiarrhythmic drugs) or procedures. Antiarrhythmic medications like flecainide, propafenone, sotalol, dofetilide, and amiodarone can maintain normal rhythm in some patients, though each carries specific side effect profiles that require monitoring.
Electrical cardioversion uses a controlled electrical shock delivered through paddles or pads on the chest to reset the heart's rhythm. It is effective for terminating AFib episodes but does not prevent recurrence without ongoing antiarrhythmic medication or procedural intervention.
Catheter ablation has become the most effective long-term rhythm control strategy. During this procedure, a catheter is threaded through blood vessels to the heart, and targeted energy (radiofrequency heat or cryotherapy cold) destroys the abnormal electrical pathways that trigger and sustain AFib. Success rates for paroxysmal AFib ablation range from 70 to 90 percent, with many patients achieving long-term freedom from AFib. The Mayo Clinic provides detailed information on the ablation procedure.
Stroke Prevention
For most AFib patients with additional stroke risk factors (CHA₂DS₂-VASc score of 2 or higher in men, 3 or higher in women), long-term anticoagulation (blood-thinning medication) is recommended. Direct oral anticoagulants (DOACs) — including apixaban (Eliquis), rivarelbafan (Xarelto), dabigatran (Pradaxa), and edoxaban (Savaysa) — have largely replaced warfarin as the preferred anticoagulants due to their more predictable effects, fewer food and drug interactions, and no requirement for routine blood monitoring.
For patients who cannot take blood thinners, left atrial appendage closure devices (such as the Watchman device) offer an alternative stroke prevention strategy by sealing off the atrial appendage where most clots form.
Lifestyle Modifications
Lifestyle changes are a critical and often underemphasized component of AFib management. Weight loss in obese patients reduces AFib burden more than any single medication. A landmark study showed that a 10 percent weight loss resulted in sixfold greater likelihood of long-term AFib freedom compared to patients who did not lose weight.
Treating obstructive sleep apnea with CPAP therapy reduces AFib recurrence after cardioversion and ablation. Untreated sleep apnea nearly doubles the risk of AFib recurrence after ablation.
Moderate regular exercise (avoiding excessive endurance training) improves cardiovascular fitness, reduces AFib triggers, and improves rate control. Limiting alcohol consumption — ideally to no more than one drink per day, or abstaining entirely if alcohol triggers episodes — reduces AFib burden. Managing stress through relaxation techniques, mindfulness, and adequate sleep helps reduce sympathetic nervous system activation that can trigger AFib episodes.
Avoiding known triggers is individualized but commonly includes excessive caffeine (though moderate coffee consumption appears safe for most AFib patients), dehydration, large heavy meals, extreme temperatures, and emotional stress.
Living With AFib
An AFib diagnosis can feel frightening, but the condition is manageable for the vast majority of patients. Stay informed about your condition, take medications as prescribed, attend regular follow-up appointments, and communicate openly with your cardiologist about symptoms and concerns.
Modern treatments — from effective anticoagulants that dramatically reduce stroke risk to catheter ablation procedures that can eliminate AFib entirely — mean that most people with atrial fibrillation can lead active, fulfilling lives with appropriate medical management and lifestyle optimization. The key is early detection, comprehensive treatment, and ongoing partnership with your healthcare team.
Sources and Further Reading
Health and Beyond uses reputable medical and scientific sources where possible. These links support or expand on the topics discussed above.
- American Heart Associationheart.org
- The Mayo Clinicmayoclinic.org
